Marinus selling rare pediatric disease priority review voucher for $110M
July 14, 2022 at 11:07 AM EDT
The FDA awarded the Radnor company the lucrative voucher after its seizure drug Ztalmy was approved in March.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
